NEW YORK U.S. drug maker Pfizer Inc's $160 billion agreement to acquire Botox maker Allergan Plc was on the brink of being abandoned on Tuesday, after the U.S. Treasury issued new rules on how tax "inversion" deals can be structured.
Allergan's shares were hit considerably hard on Tuesday, showing how the rules that were issued on Monday targeted the biggest inversion attempted to date. The federal government has grappled with a wave of recent inversions by U.S. companies seeking to slash their tax bills by redomiciling overseas...
00:02 AT&T Aims for an Empire in Merger Talks With Time Warner5
23:06 AT&T discussed takeover in meetings with Time Warner: Bloomberg
16:51 Scottrade Sale Nearly Doubles Owner’s Wealth to $4 Billion8
21:31 Time Warner jumps after hours on report it could sell for $110 per share to AT&T1